Variant report
Variant | nsv828510 |
---|---|
Chromosome Location | chr19:23218487-23222278 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574799492 | chr19:23218550-23218551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs534661607 | chr19:23218551-23218552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs537323905 | chr19:23218552-23218553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372951276 | chr19:23218554-23218555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536810040 | chr19:23218556-23218557 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537388776 | chr19:23218598-23218599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs368928001 | chr19:23218644-23218645 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73555435 | chr19:23218671-23218672 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs534611329 | chr19:23218836-23218837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192024430 | chr19:23218842-23218843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577262500 | chr19:23218844-23218845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575639936 | chr19:23218846-23218847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563205853 | chr19:23218883-23218884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575321158 | chr19:23218935-23218936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs118098738 | chr19:23218945-23218946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs561477440 | chr19:23218951-23218952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs528787669 | chr19:23218983-23218984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547364302 | chr19:23219032-23219033 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143429547 | chr19:23219057-23219058 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs184842578 | chr19:23219069-23219070 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544643822 | chr19:23219089-23219090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs187744543 | chr19:23219147-23219148 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569223468 | chr19:23219209-23219210 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs536751775 | chr19:23219212-23219213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs548863318 | chr19:23219226-23219227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs77708251 | chr19:23219233-23219234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs377444654 | chr19:23219242-23219243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10424608 | chr19:23219275-23219276 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs552886142 | chr19:23219385-23219386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs138569316 | chr19:23219451-23219452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs538229706 | chr19:23219454-23219455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs554829228 | chr19:23219493-23219494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192716590 | chr19:23219522-23219523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs575209851 | chr19:23219557-23219558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542748641 | chr19:23219570-23219571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184134905 | chr19:23219583-23219584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564684536 | chr19:23219598-23219599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs144088259 | chr19:23219664-23219665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540912352 | chr19:23219830-23219831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374358488 | chr19:23219835-23219836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs115790550 | chr19:23219848-23219849 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs56025038 | chr19:23219851-23219852 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs72540857 | chr19:23219907-23219908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs11458122 | chr19:23219908-23219909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs67834525 | chr19:23219909-23219910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562907989 | chr19:23219989-23219990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs370910439 | chr19:23220027-23220028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs147312388 | chr19:23220036-23220037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572949899 | chr19:23220059-23220060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs115410349 | chr19:23220072-23220073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chordoma | 18071362 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Cervical cancer | 21063398 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Lung cancer | 18438408 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Colorectal cancer | 20459617 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Cancer | 20164920 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:23217800-23218800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr19:23218000-23218800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr19:23218800-23219000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr19:23218800-23219200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr19:23219000-23222000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr19:23219200-23220200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr19:23220200-23220400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr19:23220200-23221400 | Enhancers | Fetal Heart | heart |
9 | chr19:23220400-23220800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr19:23220800-23221200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
11 | chr19:23222000-23222400 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |